Tumor mutational burden (TMB) is most relevant in predicting response to:
Show answer and explanation
Correct answer: Immune checkpoint inhibitors
High tumor mutational burden is associated with better response to immune checkpoint inhibitors. Increased mutations may generate more neoantigens, enhancing immune recognition.
Keep practicing
More Precision Medicine questions
- Which biomarker is commonly tested to determine eligibility for anti-EGFR therapy in colorectal cancer?
- Liquid biopsy primarily involves analysis of:
- Pharmacogenomics studies the relationship between:
- Which gene mutation is commonly targeted in non-small cell lung carcinoma with tyrosine kinase inhibitors?
- Microsatellite instability (MSI) testing is particularly important in:
- Which sequencing approach targets only selected genes of interest?